Kevin Hanley

Axtria, Inc. provides customized analytics software and client consulting services. The firm?s solutions include decision science, commercial operations cloud and cloud information management. The company was founded by Jaswinder S. Chadha and Navdeep Chadha in 2010 and is headquartered in Berkeley Heights, NJ.

Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA.

Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA.

marketRx LLC offers analytics, market research and software services to life sciences companies. It delivers sales management and operations, brand marketing and product management, and market research services. The company was founded in 2000 and is headquartered in Bridgewater, NJ.

New Jersey Technology Council provides business development, education and advocacy services. It serves communications, e-business, multimedia, consumer technologies, manufacturing, engineering and energy sectors. The company was founded in 1996 and is headquartered in New Brunswick, NJ.

The Indus Entrepreneurs is a non-profit organization. It provides mentoring, networking, education and funding to entrepreneurs. The company was founded in 1992 and is headquartered in Santa Clara, CA.

Instylla, Inc. operates as a biotechnology company. Its focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis. The company was founded by Amarpreet Sawhney and is headquartered in Waltham, MA.

Ostial Corp. develops catheter-based delivery system combined with a bare metal stent. The firm allows physicians to perform aorto-ostial interventions with precision and predictability. The company was founded by Fred Khosravi in 2008 and is headquartered in Campbell, CA.

TiE Boston is a private equity firm founded by by Desh Deshpande in 1997. The firm is headquartered in Boston, MA.

Incept LLC operates as a biotechnical research company. It focuses in the life-sciences space, and occasional involvement in select information technology opportunities. The company was founded in 1998 by Farhad Khosravi and Amarpreet S. Sawhney and is headquartered in San Mateo, CA.

A.T. Kearney, Inc. engages in the provision of management consulting services. Its services include strategic, operational and technology consulting executive search services. The company was founded by Andrew Thomas Kearney in 1926 and is headquartered in Chicago, IL.

Cellemedy Co., Ltd. develops next-generation cancer treatments to improve the health of people suffering from cancer. The company is based in Seongnam-si, South Korea. The South Korean company was founded in 2016. The CEO is Ha-Chul Kim.

Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA.

Cybernetix Ventures Management Co.LLC (Cybernetix Ventures ) is a venture capital firm founded in 2018 by Mark Martin and Fady Saad. The firm headquartered in Boston, Massachusetts.

Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT.

Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom.

Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation.

Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA.

Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA.

Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA.

Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA.

Zeneca Pharmaceuticals manufactures medicines.